Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling
R J Bernardi, D L Trump, W D Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis
P A Hershberger, W D Yu, R A Modzelewski, et al.
Cancer Research
|
September 1, 1997
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system
B W Light, W D Yu, M C McElwain, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|
August 21, 2018
[Cytotoxic effects of γδT cells on bladder cancer cells and expression of MICA/B in bladder cancer]
J H Zhou, D Wang, H R Wang, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice
C S Johnson, M J Chang, W D Yu, et al.
Journal of the National Cancer Institute
|
February 5, 1998
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone
W D Yu, M C McElwain, R A Modzelewski, et al.
Cancer Research
|
October 15, 1994
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model
M J Chang, W D Yu, L M Reyno, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling
R J Bernardi, D L Trump, W D Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis
P A Hershberger, W D Yu, R A Modzelewski, et al.
Cancer Research
|
September 1, 1997
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system
B W Light, W D Yu, M C McElwain, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|
August 21, 2018
[Cytotoxic effects of γδT cells on bladder cancer cells and expression of MICA/B in bladder cancer]
J H Zhou, D Wang, H R Wang, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice
C S Johnson, M J Chang, W D Yu, et al.
Journal of the National Cancer Institute
|
February 5, 1998
Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone
W D Yu, M C McElwain, R A Modzelewski, et al.
Cancer Research
|
October 15, 1994
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model
M J Chang, W D Yu, L M Reyno, et al.
Page
of 3